The antibacterial peptide ABP-CM4: the current state of its production and applications

Amino Acids. 2012 Jun;42(6):2393-402. doi: 10.1007/s00726-011-0982-3. Epub 2011 Jul 30.

Abstract

The increasing resistance of bacteria and fungi to currently available antibiotics is a major concern worldwide, leading to enormous efforts to develop new antibiotics with new modes of actions. Antibacterial peptide CM4 (ABP-CM4) is a small cationic peptide with broad-spectrum activities against bacteria, fungi, and tumor cells, which may possibly be used as a promising candidate for a new antibiotic. For pharmaceutical applications, a large quantity of antimicrobial peptides needs to be produced economically. In this communication, the progress in the structural characteristics, heterologous production, and biological evaluation of ABP-CM4 are reviewed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Amino Acid Sequence
  • Anti-Infective Agents / metabolism
  • Anti-Infective Agents / pharmacology
  • Antimicrobial Cationic Peptides / biosynthesis*
  • Antimicrobial Cationic Peptides / genetics
  • Antimicrobial Cationic Peptides / pharmacology
  • Circular Dichroism
  • Cloning, Molecular
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Fungi / drug effects
  • Gene Expression
  • Humans
  • Microbial Sensitivity Tests
  • Models, Molecular
  • Molecular Sequence Data
  • Pichia / genetics
  • Pichia / metabolism
  • Protein Structure, Secondary
  • Recombinant Fusion Proteins / biosynthesis*
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology

Substances

  • Anti-Infective Agents
  • Antimicrobial Cationic Peptides
  • CM4 peptide, Bombyx mori
  • Recombinant Fusion Proteins